NEWS

LIMS product deployed by top-five pharma company

Sapio Sciences has licensed its Exemplar LIMS product to one of the top five pharmaceutical companies in the world, to help organise its genetics research.

The pharma company currently produces thousands of samples, which could soon grow into millions in the near future. The software provides straightforward wizards to handle the samples automatically, which may then be tracked using 1D and 2D barcodes. The built in reagent protocols for Illumina and Affymetrix platforms eliminate the need for paper tracking of lab procedures.

If this approach seems to be verging on the ELN market, it was wholly deliberate, according to Kevin Cramer, CEO at Sapio, who says the product also integrates bioinformatics systems. ‘We felt from the beginning that intuitively all these product categories should really be one product. In fact, we are going to extend that definition even further to say that certain analytics results and even clinical trial management should be part of a complete LIMS solution.’

The Exemplar LIMS BioBanking module helps the laboratories of the company, whose name has not been disclosed, to adhere to Good Laboratory Practices regulations and FDA CFP 11 Part 21 patent regulations.

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

Sophia Ktori highlights the role of the laboratory software in the use of medical diagnostics

Feature

Gemma Church explores the use of modelling and simulation to predict weather and climate patterns

Feature

Robert Roe reviews the latest in accelerator technology and finds that GPUs and coprocessors will be key fixtures in the future of deep learning

Feature

Robert Roe finds that commoditisation of flash and SSD technology and the uptake of machine learning and AI applications are driving new paradigms in storage technology.